Comparison of Tuberculosis and CoVID-19 Prevention and Control Policies: A Systematic Review
DOI:
https://doi.org/10.61173/adfcbb29Keywords:
Tuberculosis, COVID-19, public health measuresAbstract
mwymwAbstract: Tuberculosis, is a contagious respiratory condition caused by infection with the bacterium Mycobacterium tuberculosis. With the rapid prevalence of COVID-19, the multifaceted public health interventions, including non-pharmaceutical measures have been conducted. Results showed that the public health policies implemented by China during the COVID-19 outbreak have had a positive impact on controlling the development of tuberculosis. This paper explores the interplay between tuberculosis (TB) control and the public health measures implemented during the COVID-19 pandemic in China. It highlights how non-pharmaceutical interventions (NPIs) such as travel restrictions, social distancing, mask-wearing, and early case detection, initially designed to contain COVID-19, also contributed to reducing TB transmission. Additionally, the rapid development of China’s public health infrastructure and the use of digital technologies during the pandemic enhanced TB surveillance, diagnosis, and treatment adherence. Key interventions included electronic patient service systems, digital adherence technologies (DATs), and integrated digital platforms that improved treatment outcomes. However, challenges such as reduced TB notifications during COVID-19 and financial constraints in TB management were identified. The paper emphasizes the importance of policy adaptations, technological innovations, and sustainable healthcare reforms to address TB in a post-pandemic world. China’s experience provides valuable insights for future infectious disease control, demonstrating how coordinated public health strategies can effectively manage multiple health challenges simultaneously.
References
[1] A. Pan, Li Liu et al. “Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China..” Journal of the American Medical Association (JAMA)(2020).
[2] Xifeng Wu and Y. Ye. “A Public Health Perspective on Preventing and Controlling the Spread of Coronavirus Disease 2019.” China CDC Weekly (2020). 237 - 240.
[3] Qian Jiang, Zhijun Liu et al. “A tuberculosis model with early and late latency, imperfect vaccination, and relapse: An application to China.” Mathematical methods in the applied sciences (2023). 10929 - 10946.
[4] Wenjing Gao and Liming Li. “Cold-chain transmission, asymptomatic infection, mass screening, vaccine, and modelling: what we know so far for coronavirus disease 2019 control and experience in China.” Medical Review (2022). 1 - 2.
[5] Qi Wu, B. Chen et al. “Insights from COVID-19: Reflecting on the Promotion of Long-Term Health Policies in China.” International Journal of Environmental Research and Public Health (2023).
[6] D. Chin. “The COVID-19 Pandemic and Elimination of Tuberculosis in China.” China CDC Weekly (2021). 260 - 264.
[7] Pengfei Wei, Zelang Cai et al. “Pains and Gains from China‘s Experiences with Emerging Epidemics: From SARS to H7N9.” BioMed Research International (2016).
[8] S. Lai, N. Ruktanonchai et al. “Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China.” medRxiv (2020).
[9] Z. Yuan. “Non-pharmaceutical interventions taken by China during the prevention and control of COVID-19.” Highlights in Science Engineering and Technology (2022).
[10] Yao Yao, Hanchu Zhou et al. “Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China.” J. Am. Medical Informatics Assoc. (2023).
[11] S. Yerlikaya, Lydia Holtgrewe et al. “Innovative COVID-19 point-of-care diagnostics suitable for tuberculosis diagnosis: a scoping review protocol.” BMJ Open (2023).
[12] Mengxian Zhang, Guiyang Wang et al. “Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020– 2021: Impact on medication adherence.” Frontiers in Public Health (2023).
[13] Xiaojun Wang, Qian Fu et al. “How Integrated Digital Tools Can Improve Tuberculosis Medication Adherence: A Longitudinal Study in China..” Telemedicine journal and e-health (2023).
[14] N. Ni, N. Wang et al. “Current status and future prospects of TB digital treatment adherence technology use in China..” The International Journal of Tuberculosis and Lung Disease (2023).438-443.
[15] Hsien-Ho Lin, Lixia Wang et al. “Tuberculosis control in China: use of modelling to develop targets and policies.” Bulletin of the World Health Organization (2015). 790 - 798.
[16] Yang Chen, Qingyu Zhou et al. “Influence of Public Health Services on the Goal of Ending Tuberculosis: Evidence From Panel Data in China.” Frontiers in Public Health (2022). Dean&Francis Xiangbo Sun
[17] S. Squire and Shenglan Tang. “The effect of tuberculosis control in China. Comment.” (2004). 417-422.
[18] Y. Cui, Hui Shen et al. “A Long-Term Trend Study of Tuberculosis Incidence in China, India and United States 1992–2017: A Joinpoint and Age–Period–Cohort Analysis.” International Journal of Environmental Research and Public Health (2020).
[19] Xiaolin Wei, G. Zou et al. “China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data.” PLoS ONE (2014).
[20] Weiwei Duan and Tianbao Qin. “The Impact of China’s Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.” International Journal of Environmental Research and Public Health (2022).
[21] Q. Long, Weixi Jiang et al. “A New Financing Model for Tuberculosis (TB) Care in China: Challenges of Policy Development and Lessons Learned from the Implementation.” International Journal of Environmental Research and Public Health (2020).
[22] Mingniu Dong, Cheng Zhou et al. “Analyzing the Characteristics of Policies and Political Institutions for the Prevention and Control Governance of the COVID-19 Pandemic: Evidence from China.” International Journal of Environmental Research and Public Health (2022).
[23] Qiao Liu, P. Lu et al. “Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China.” Clinical Infectious Diseases (2020).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
